We are happy to announce that Calmino group AB and Aboutmeds (Ranua, Finland) have entered into an exclusive distribution agreement for Finland in order to launch PROIBS® for the treatment of symptoms related to IBS. Read more about PROIBS® and where to buy it in...
The PharmaSynergy conference connects global pharma professionals and showcases pharma opportunities for internationalization, in/out-licensing, investment and portfolio development. Calmino group AB will attend the conference in Berlin, 15-16th September this year....
We are happy to announce that Calmino group AB and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the territories of Czech Republic and Slovakia in order to launch PROIBS® for the treatment of symptoms related to IBS....
Calmino group AB is proud to announce that PROIBS® will soon be available in two more European countries. Calmino group AB signs an exclusive distribution agreement for PROIBS® in the territory of Czech Republic and Slovakia to be launched later this year. Don’t...
HAPPY HOLIDAYS! Merry Christmas and a Happy New Year! Learn more about PROIBS® What is PROIBS®? PROIBS® is a certified medical device product for the treatment of symptoms related to IBS such as abdominal pain, bloating and changes in bowel movement (diarrhoea...
Recent Comments